Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
JASINT 1
Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
Therapeutic area :
Oncology
Disease :
Carcinoma of the urothelium
Study medication :
Vinflunine (Javlor®)
Phase :
Phase II
Start Date :
05 October 2010
End date :
22 November 2010
Study ID :
L00070 IN 213 PI
EudraCT/CTIS number :
2010-020620-22
Send by email